{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "50242-215",
      "generic_name": "omalizumab",
      "labeler_name": "Genentech, Inc.",
      "brand_name": "Xolair PFS",
      "active_ingredients": [
        {
          "name": "OMALIZUMAB",
          "strength": "150 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "50242-215-03",
          "description": "1 SYRINGE, GLASS in 1 CARTON (50242-215-03)  / 1 mL in 1 SYRINGE, GLASS",
          "marketing_start_date": "20230818",
          "sample": false
        },
        {
          "package_ndc": "50242-215-55",
          "description": "1 SYRINGE, GLASS in 1 CARTON (50242-215-55)  / 1 mL in 1 SYRINGE, GLASS",
          "marketing_start_date": "20230818",
          "sample": false
        },
        {
          "package_ndc": "50242-215-83",
          "description": "1 SYRINGE, GLASS in 1 CARTON (50242-215-83)  / 1 mL in 1 SYRINGE, GLASS",
          "marketing_start_date": "20230818",
          "sample": true
        },
        {
          "package_ndc": "50242-215-99",
          "description": "1 SYRINGE, GLASS in 1 CARTON (50242-215-99)  / 1 mL in 1 SYRINGE, GLASS",
          "marketing_start_date": "20230818",
          "sample": true
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Genentech, Inc."
        ],
        "rxcui": [
          "1657209",
          "1657212",
          "2058943",
          "2058946",
          "2058949",
          "2058950",
          "2663917",
          "2663918",
          "2663920",
          "2663923",
          "2673760",
          "2673761",
          "2673762",
          "2673763"
        ],
        "spl_set_id": [
          "7f6a2191-adfb-48b9-9bfa-0d9920479f0d"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175794",
          "N0000175793",
          "N0000175792"
        ],
        "pharm_class_epc": [
          "Anti-IgE [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased IgE Activity [PE]"
        ],
        "pharm_class_moa": [
          "IgE-directed Antibody Interactions [MoA]"
        ],
        "unii": [
          "2P471X1Z11"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "48785e56-4828-4f55-88e1-eca2cb88299d",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20180928",
      "product_id": "50242-215_48785e56-4828-4f55-88e1-eca2cb88299d",
      "application_number": "BLA103976",
      "brand_name_base": "Xolair PFS",
      "pharm_class": [
        "Anti-IgE [EPC]",
        "Decreased IgE Activity [PE]",
        "IgE-directed Antibody Interactions [MoA]"
      ]
    }
  ]
}